![Models for antimicrobial R&D: <br>Computational modelling for population PK and PKPD</br>](https://revive.gardp.org/wp-content/uploads/2019/06/GARDP_REVIVE_Poster_August-2019_new-colours-scaled-1.jpg)
Models for antimicrobial R&D: Computational modelling for population PK and PKPD
more![Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research](https://revive.gardp.org/wp-content/uploads/2019/04/GARDP_REVIVE_Poster_June2019_new-colours-scaled-1.jpg)
Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research
more![Mining Chemical Libraries for New Antibacterials](https://revive.gardp.org/wp-content/uploads/2019/03/GARDP_REVIVE_Poster_May2019_new-colours-scaled-1.jpg)
Mining Chemical Libraries for New Antibacterials
more![<br>Antibacterial drugs: Clinical development for non-developers </br> Part 3: Non-traditional approaches](https://revive.gardp.org/wp-content/uploads/2019/02/GARDP_REVIVE_Poster_January2019_3_new-colours-scaled-1.jpg)
Antibacterial drugs: Clinical development for non-developers Part 3: Non-traditional approaches
more![Making Safety a Part of Drug Design](https://revive.gardp.org/wp-content/uploads/2018/10/CS1_poster_final_new-colours-1-scaled-1.jpg)
Making Safety a Part of Drug Design
more![<br>Antibacterial drugs: Clinical development for non-developers </br> Part 2: Development of antibacterial drugs targeting specific pathogens](https://revive.gardp.org/wp-content/uploads/2018/08/GARDP_REVIVE_Poster_September2018_new-colours-1-scaled-1.jpg)